Peregrine Investment Management’s Beam Therapeutics BEAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.5M	Buy	264,260 +40,000	+18%	+$680K	2.87%	18
2025 Q1	$4.38M	Buy	224,260 +65,710	+41%	+$1.28M	3.27%	16
2024 Q4	$3.93M	Buy	+158,550	New	+$3.93M	2.28%	22